Table 2 Summary of clinical characteristics

Preoperative screening:

28 preoperative cervical TCT

1 CIN stage III

3 with atypical squamous cells

1 inflammation

2 cervicitis

6 curettage

1 with necrotic tissues and pelvic mass

1 uterine clear cell carcinoma

1 endometrial adenocarcinoma

2 no abnormal tissues

1 endometrium not found

Pathology:

Type:

1 undifferentiated carcinoma

1 undifferentiated and transitional cell carcinoma

34 adenocarcinoma

24 pure adenocarcinoma

10 mixed type

Complication:

7 complicated with clear cell carcinoma

2 complicated with endometrial cancer

1 complicated with transitional cell carcinoma

Differentiation:

5 moderately differentiated

29 poorly to moderately, or simply poorly, differentiated

2 undifferentiated

Sites:

33 unilateral fallopian cancer

3 bilateral fallopian cancer

13 with involvement in ovary

4 with uterine transfer

3 with myometrial invasion

1 with endometrial involvement

14 with pelvic metastasis in omentum

8 with retroperitoneal lymph node metastasis

Surgical Staging:

Early stage: (47.2%)

4 stage Ia

5 stage Ic

2 stage IIa

1 stage IIb

5 stage IIc

Advanced Stage: (52.8%)

2 stage IIIb

17 stage IIIc

Intraoperative residual tumor:

18 with residual tumor

7 with diameter more than 1 cm

11 with diameter less than 1 cm

14 without residual tumor

4 without records

CA125:

19 had elevated preoperative CA125

2 stage Ic

3 stage IIc

1 stage IIIb

13 stage IIIc

Follow-up and relapse:

General:

4 drop-outs

12 with relapse or metastasis (33.3%)

10 death

1 stage Ic

1 stage IIc

2 stage IIIb

6 stage IIIc

2 live with tumor

Sites of relapse:

1 on vaginal stump

4 with pelvic relapse

4 with peritoneal relapse

3 with significantly elevated CA125 yet no lesions found